Search type: go_term
Results for query: immune response
| Gene Symbol | Gene Name | Links to Senescence |
|---|---|---|
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase |
U: 1
|
| ACKR2 | atypical chemokine receptor 2 |
U: 1
|
| ACOD1 | aconitate decarboxylase 1 | |
| ADAM15 | a disintegrin and metallopeptidase domain 15 (metargidin) |
U: 1
|
| ADAM8 | a disintegrin and metallopeptidase domain 8 |
D: 1
|
| ADAR | adenosine deaminase, RNA-specific |
U: 1
|
| ADCY7 | adenylate cyclase 7 |
U: 1
|
| ADGRE1 | adhesion G protein-coupled receptor E1 |
D: 2
|
| ADGRE5 | adhesion G protein-coupled receptor E5 |
U: 1
D: 1
|
| AGER | advanced glycosylation end-product specific receptor |
U: 2
D: 1
|
| AIM2 | absent in melanoma 2 |
U: 1
|
| AKIRIN2 | akirin 2 |
D: 1
|
| ALCAM | activated leukocyte cell adhesion molecule |
U: 2
D: 1
|
| ALOX15 | arachidonate 15-lipoxygenase |
U: 1
|
| ALOX5 | arachidonate 5-lipoxygenase |
U: 2
|
| ALPK1 | alpha-kinase 1 |
U: 1
|
| ANGPT1 | angiopoietin 1 |
U: 3
D: 3
|
| ANKHD1 | ankyrin repeat and KH domain containing 1 |
U: 1
|
| ANXA1 | annexin A1 |
U: 2
D: 1
|
| APLN | apelin |
U: 1
D: 3
|
| APOA1 | apolipoprotein A-I |
U: 3
|
| APOBEC3B | apolipoprotein B mRNA editing enzyme catalytic subunit 3B |
U: 1
D: 5
|
| APOBEC3C | apolipoprotein B mRNA editing enzyme catalytic subunit 3C |
U: 1
|
| APOBEC3F | apolipoprotein B mRNA editing enzyme catalytic subunit 3F |
U: 1
|
| APOBEC3G | apolipoprotein B mRNA editing enzyme catalytic subunit 3G |
U: 1
|
| APOE | apolipoprotein E |
U: 4
D: 2
|
| APOL1 | apolipoprotein L1 |
U: 4
D: 1
|
| APP | amyloid beta (A4) precursor protein |
U: 6
D: 2
|
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
D: 2
|
| APPL2 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
D: 1
|
| ARG1 | arginase, liver |
U: 3
|
| ARG2 | arginase type II |
U: 5
D: 2
|
| ARHGEF2 | rho/rac guanine nucleotide exchange factor (GEF) 2 |
D: 3
|
| ARID5A | AT rich interactive domain 5A (MRF1-like) |
U: 2
D: 1
|
| ATG5 | autophagy related 5 |
U: 3
D: 4
|
| ATP6V0A2 | ATPase H+ transporting V0 subunit a2 |
D: 2
|
| AXL | AXL receptor tyrosine kinase |
U: 1
D: 4
|
| ANG | angiogenin, ribonuclease, RNase A family, 5 |
U: 2
D: 1
|
| ATG9A | autophagy related 9A |
U: 3
|
| B2M | beta-2 microglobulin |
U: 5
D: 1
|
| BCL10 | B cell leukemia/lymphoma 10 |
U: 1
D: 1
|
| BCL2 | BCL2 apoptosis regulator |
U: 11
D: 5
|
| BCL3 | B cell leukemia/lymphoma 3 |
U: 1
D: 3
|
| BCL6 | B cell leukemia/lymphoma 6 |
U: 3
D: 1
|
| BCL6B | B cell CLL/lymphoma 6, member B |
U: 1
D: 1
|
| BIRC2 | baculoviral IAP repeat containing 2 |
U: 1
D: 1
|
| BIRC3 | baculoviral IAP repeat containing 3 |
U: 3
D: 2
|
| BLK | B lymphoid kinase |
U: 1
|
| BMP6 | bone morphogenetic protein 6 |
U: 2
D: 1
|
| BMPR1A | bone morphogenetic protein receptor, type 1A |
D: 1
|
| BST1 | bone marrow stromal cell antigen 1 |
U: 2
|
| BST2 | bone marrow stromal cell antigen 2 |
U: 5
D: 2
|
| BTK | Bruton agammaglobulinemia tyrosine kinase |
U: 4
D: 1
|
| BTN2A1 | butyrophilin subfamily 2 member A1 |
U: 1
D: 1
|
| BTN2A2 | butyrophilin, subfamily 2, member A2 |
U: 1
|
| BTN2A3P | butyrophilin subfamily 2 member A3, pseudogene |
D: 1
|
| BTN3A1 | butyrophilin subfamily 3 member A1 |
U: 2
|
| BTN3A2 | butyrophilin subfamily 3 member A2 |
U: 1
D: 1
|
| BTN3A3 | butyrophilin subfamily 3 member A3 |
U: 2
D: 2
|
| BCAP31 | B cell receptor associated protein 31 |
U: 2
D: 1
|
| BMI1 | Bmi1 polycomb ring finger oncogene |
U: 4
D: 28
|
| C1QBP | complement component 1, q subcomponent binding protein |
U: 1
D: 3
|
| C1R | complement C1r |
U: 4
|
| C1RL | complement component 1, r subcomponent-like |
U: 3
|
| C1S | complement C1s |
U: 3
|
| C2 | complement C2 |
D: 1
|
| C3 | complement C3 |
U: 9
D: 1
|
| C4A | complement C4A (Rodgers blood group) |
U: 1
D: 1
|
| C4B | complement component 4B (Chido blood group) |
D: 1
|
| C5AR1 | complement C5a receptor 1 |
U: 2
D: 1
|
| C8G | complement component 8, gamma polypeptide |
U: 1
|
| CAMK4 | calcium/calmodulin-dependent protein kinase IV |
D: 3
|
| CAMP | cathelicidin antimicrobial peptide |
U: 1
D: 1
|
| CAPZA2 | capping actin protein of muscle Z-line subunit alpha 2 |
U: 1
D: 1
|
| CARD9 | caspase recruitment domain family, member 9 |
U: 1
|
| CASP4 | caspase 4, apoptosis-related cysteine peptidase |
U: 2
D: 2
|
| CCL2 | chemokine (C-C motif) ligand 2 |
U: 39
D: 6
|
| CCL20 | chemokine (C-C motif) ligand 20 |
U: 9
|
| CCL27 | C-C motif chemokine ligand 27 |
D: 1
|
| CCL28 | chemokine (C-C motif) ligand 28 |
U: 1
|
| CCL4 | chemokine (C-C motif) ligand 4 |
U: 5
|
| CCL5 | chemokine (C-C motif) ligand 5 |
U: 13
D: 1
|
| CCR1 | chemokine (C-C motif) receptor 1 |
U: 2
D: 1
|
| CCR7 | chemokine (C-C motif) receptor 7 |
U: 2
D: 1
|
| CD14 | CD14 antigen |
U: 2
|
| CD164 | CD164 molecule |
U: 1
|
| CD177 | CD177 antigen |
U: 3
|
| CD180 | CD180 antigen |
D: 1
|
| CD200 | CD200 antigen |
U: 1
D: 1
|
| CD24 | CD24 molecule |
U: 2
|
| CD27 | CD27 molecule |
D: 1
|
| CD274 | CD274 antigen |
U: 2
D: 1
|
| CD276 | CD276 antigen |
U: 1
D: 1
|
| CD28 | CD28 antigen |
U: 1
D: 2
|
| CD33 | CD33 molecule |
U: 1
|
| CD34 | CD34 molecule |
U: 2
D: 3
|
| CD4 | CD4 antigen |
D: 1
|
| CD40 | CD40 antigen |
U: 1
|
| CD40LG | CD40 ligand |
U: 1
|
| CD46 | CD46 molecule |
U: 1
D: 2
|
| CD55 | CD55 molecule, decay accelerating factor for complement |
U: 1
|
| CD6 | CD6 molecule |
U: 1
|
| CD74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
D: 4
|
| CD81 | CD81 antigen |
U: 2
D: 1
|
| CD83 | CD83 molecule |
U: 2
|
| CD86 | CD86 antigen |
U: 1
|
| CD8A | CD8 antigen, alpha chain |
U: 1
|
| CD96 | CD96 molecule |
D: 1
|
| CD99 | CD99 molecule (Xg blood group) |
U: 1
|
| CEBPB | CCAAT enhancer binding protein beta |
U: 9
D: 1
|
| CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma |
U: 1
D: 2
|
| CERT1 | ceramide transporter 1 | |
| CFI | complement component factor i |
U: 3
|
| CGAS | cyclic GMP-AMP synthase |
U: 7
|
| CHGA | chromogranin A |
D: 1
|
| CHID1 | chitinase domain containing 1 |
U: 1
|
| CHUK | component of inhibitor of nuclear factor kappa B kinase complex |
U: 2
D: 2
|
| CIITA | class II major histocompatibility complex transactivator |
D: 1
|
| CLU | clusterin |
U: 3
D: 5
|
| CMKLR1 | chemerin chemokine-like receptor 1 |
U: 1
D: 2
|
| CNIH1 | cornichon family AMPA receptor auxiliary protein 1 |
U: 1
D: 1
|
| CNPY3 | canopy FGF signaling regulator 3 |
U: 1
D: 1
|
| COCH | cochlin |
U: 2
D: 1
|
| COL17A1 | collagen type XVII alpha 1 chain |
D: 2
|
| COL1A1 | collagen type I alpha 1 chain |
U: 9
D: 9
|
| COL1A2 | collagen type I alpha 2 chain |
U: 4
D: 2
|
| COL2A1 | collagen type II alpha 1 chain |
U: 2
D: 3
|
| COL3A1 | collagen, type III, alpha 1 |
U: 5
D: 4
|
| COLEC12 | collectin sub-family member 12 |
U: 3
D: 1
|
| CORO1A | coronin 1A |
D: 3
|
| CRACR2A | calcium release activated channel regulator 2A |
D: 1
|
| CRCP | calcitonin gene-related peptide-receptor component protein |
D: 1
|
| CRIP1 | cysteine rich protein 1 |
D: 1
|
| CRISP3 | cysteine rich secretory protein 3 |
U: 1
|
| CRP | C-reactive protein, pentraxin-related |
U: 1
|
| CSF1 | colony stimulating factor 1 (macrophage) |
U: 5
|
| CSF1R | colony stimulating factor 1 receptor |
U: 1
D: 2
|
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
U: 11
D: 2
|
| CSF3 | colony stimulating factor 3 (granulocyte) |
U: 7
D: 1
|
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 |
U: 1
|
| CTSC | cathepsin C |
D: 2
|
| CTSH | cathepsin H |
U: 3
|
| CTSK | cathepsin K |
U: 3
D: 3
|
| CTSL | cathepsin L |
U: 2
|
| CTSS | cathepsin S |
U: 5
|
| CTSV | cathepsin V |
U: 2
D: 1
|
| CX3CL1 | chemokine (C-X3-C motif) ligand 1 |
U: 4
|
| CXADR | CXADR Ig-like cell adhesion molecule |
U: 4
|
| CXCL1 | chemokine (C-X-C motif) ligand 1 |
U: 27
D: 7
|
| CXCL10 | chemokine (C-X-C motif) ligand 10 |
U: 11
|
| CXCL11 | chemokine (C-X-C motif) ligand 11 |
U: 3
|
| CXCL12 | chemokine (C-X-C motif) ligand 12 |
U: 4
D: 5
|
| CXCL13 | chemokine (C-X-C motif) ligand 13 |
U: 2
|
| CXCL2 | chemokine (C-X-C motif) ligand 2 |
U: 16
D: 5
|
| CXCL3 | chemokine (C-X-C motif) ligand 3 |
U: 5
D: 1
|
| CXCL5 | chemokine (C-X-C motif) ligand 5 |
U: 9
D: 1
|
| CXCL6 | C-X-C motif chemokine ligand 6 |
U: 7
|
| CXCL8 | C-X-C motif chemokine ligand 8 |
U: 49
D: 11
|
| CXCL9 | chemokine (C-X-C motif) ligand 9 |
U: 3
|
| CXCR1 | chemokine (C-X-C motif) receptor 1 |
U: 1
|
| CXCR2 | chemokine (C-X-C motif) receptor 2 |
U: 5
|
| CXCR3 | chemokine (C-X-C motif) receptor 3 |
U: 1
|
| CXCR4 | chemokine (C-X-C motif) receptor 4 |
U: 6
D: 2
|
| CXCR6 | chemokine (C-X-C motif) receptor 6 |
D: 1
|
| CYBA | cytochrome b-245, alpha polypeptide |
U: 1
D: 1
|
| CYBB | cytochrome b-245, beta polypeptide |
U: 3
D: 1
|
| CYLD | CYLD lysine 63 deubiquitinase |
U: 2
|
| CYSLTR2 | cysteinyl leukotriene receptor 2 |
D: 1
|
| CARD11 | caspase recruitment domain family, member 11 |
D: 2
|
| CBLB | Casitas B-lineage lymphoma b |
U: 1
|
| CCL1 | chemokine (C-C motif) ligand 1 |
U: 3
|
| CCL11 | chemokine (C-C motif) ligand 11 |
U: 5
D: 1
|
| CCL3 | chemokine (C-C motif) ligand 3 |
U: 11
D: 1
|
| CCL7 | chemokine (C-C motif) ligand 7 |
U: 7
|
| CCL8 | chemokine (C-C motif) ligand 8 |
U: 5
|
| CCL9 | chemokine (C-C motif) ligand 9 |
U: 1
|
| CD36 | CD36 molecule |
U: 4
D: 2
|
| CD37 | CD37 antigen |
D: 4
|
| CD44 | CD44 antigen |
U: 6
D: 2
|
| CD70 | CD70 antigen |
U: 1
|
| CFB | complement factor B |
U: 2
|
| CFD | complement factor D (adipsin) |
U: 4
D: 1
|
| CFH | complement component factor h |
U: 3
D: 3
|
| CLCF1 | cardiotrophin-like cytokine factor 1 |
U: 1
|
| COLEC11 | collectin sub-family member 11 |
U: 1
|
| CXCL14 | chemokine (C-X-C motif) ligand 14 |
U: 4
D: 1
|
| DAB2IP | disabled 2 interacting protein |
U: 1
D: 1
|
| DBNL | drebrin-like |
D: 2
|
| DCLRE1C | DNA cross-link repair 1C |
D: 3
|
| DDX1 | DEAD box helicase 1 |
D: 1
|
| DDX21 | DExD box helicase 21 |
D: 3
|
| DDX58 | DEAD/H box helicase 58 |
U: 2
D: 1
|
| DDX60 | DExD/H-box helicase 60 |
U: 2
|
| DEFA6 | defensin, alpha, 6 |
U: 1
|
| DENND1B | DENN/MADD domain containing 1B |
D: 1
|
| DHX58 | DEXH (Asp-Glu-X-His) box polypeptide 58 |
U: 2
D: 1
|
| DHX9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 |
D: 2
|
| DMBT1 | deleted in malignant brain tumors 1 |
U: 1
D: 1
|
| DNASE2 | deoxyribonuclease 2, lysosomal |
U: 3
D: 1
|
| DPP8 | dipeptidyl peptidase 8 |
U: 1
D: 1
|
| DRD2 | dopamine receptor D2 |
U: 1
|
| DTX3L | deltex 3-like, E3 ubiquitin ligase |
U: 1
D: 2
|
| DUSP10 | dual specificity phosphatase 10 |
U: 2
D: 1
|
| DYSF | dysferlin |
U: 3
D: 2
|
| EBI3 | Epstein-Barr virus induced 3 |
U: 4
|
| ECM1 | extracellular matrix protein 1 |
U: 4
|
| ECSIT | ECSIT signalling integrator |
D: 2
|
| EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 |
U: 2
|
| EIF2AK4 | eukaryotic translation initiation factor 2 alpha kinase 4 |
U: 1
|
| ELANE | elastase, neutrophil expressed |
U: 1
D: 1
|
| ELF4 | E74-like factor 4 (ets domain transcription factor) |
D: 2
|
| ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 |
U: 2
D: 2
|
| ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
U: 4
D: 1
|
| ENPP3 | ectonucleotide pyrophosphatase/phosphodiesterase 3 |
D: 1
|
| EOMES | eomesodermin |
U: 2
D: 2
|
| ERAP1 | endoplasmic reticulum aminopeptidase 1 |
D: 1
|
| ERAP2 | endoplasmic reticulum aminopeptidase 2 |
U: 2
|
| EREG | epiregulin |
U: 3
D: 3
|
| ERMAP | erythroblast membrane-associated protein |
U: 1
|
| ETS1 | ETS proto-oncogene 1, transcription factor |
U: 2
D: 2
|
| EXO1 | exonuclease 1 |
U: 1
D: 6
|
| EXOSC9 | exosome component 9 |
D: 1
|
| F2RL1 | coagulation factor II (thrombin) receptor-like 1 |
U: 2
D: 1
|
| FAM3A | family with sequence similarity 3, member A |
U: 1
|
| FAS | Fas (TNF receptor superfamily member 6) |
U: 4
D: 1
|
| FBXO9 | f-box protein 9 |
U: 2
|
| FCER1G | Fc receptor, IgE, high affinity I, gamma polypeptide |
U: 1
|
| FCGR1A | Fc fragment of IgG receptor Ia |
U: 2
|
| FCGR2A | Fc fragment of IgG receptor IIa |
U: 1
|
| FCGRT | Fc receptor, IgG, alpha chain transporter |
U: 4
|
| FER | fer (fms/fps related) protein kinase |
D: 2
|
| FGL2 | fibrinogen-like protein 2 |
D: 2
|
| FKBP1A | FK506 binding protein 1a |
U: 1
|
| FOXJ1 | forkhead box J1 |
U: 1
D: 1
|
| FOXP3 | forkhead box P3 |
U: 1
|
| FRK | fyn-related kinase |
D: 1
|
| FTH1 | ferritin heavy chain 1 |
U: 3
|
| FYB1 | FYN binding protein 1 |
D: 1
|
| FYN | Fyn proto-oncogene |
D: 2
|
| G3BP1 | GTPase activating protein (SH3 domain) binding protein 1 |
D: 1
|
| G3BP2 | GTPase activating protein (SH3 domain) binding protein 2 |
U: 2
|
| GATA3 | GATA binding protein 3 |
U: 1
|
| GBF1 | golgi-specific brefeldin A-resistance factor 1 |
U: 1
|
| GBP2 | guanylate binding protein 2 |
U: 3
|
| GEM | GTP binding protein overexpressed in skeletal muscle |
U: 1
D: 1
|
| GPER1 | G protein-coupled estrogen receptor 1 |
U: 1
D: 1
|
| GPI | glucose-6-phosphate isomerase |
D: 1
|
| GPR183 | G protein-coupled receptor 183 |
U: 1
|
| GRN | granulin |
U: 3
D: 1
|
| H2BC11 | H2B clustered histone 11 | |
| H2BC12 | H2B clustered histone 12 | |
| H2BC21 | H2B clustered histone 21 | |
| HAVCR2 | hepatitis A virus cellular receptor 2 |
U: 3
|
| HCST | hematopoietic cell signal transducer |
U: 1
|
| HERC5 | HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
U: 4
|
| HEXIM1 | hexamethylene bis-acetamide inducible 1 |
U: 1
|
| HK1 | hexokinase 1 |
U: 1
|
| HLA-A | major histocompatibility complex, class I, A |
U: 3
D: 1
|
| HLA-B | major histocompatibility complex, class I, B |
U: 3
D: 2
|
| HLA-C | major histocompatibility complex, class I, C |
U: 3
D: 2
|
| HLA-DMA | major histocompatibility complex, class II, DM alpha |
U: 3
D: 1
|
| HLA-DOB | major histocompatibility complex, class II, DO beta |
U: 1
|
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 |
U: 1
D: 1
|
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 |
D: 2
|
| HLA-DRA | major histocompatibility complex, class II, DR alpha |
U: 1
D: 2
|
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
U: 2
D: 2
|
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 |
U: 1
|
| HLA-E | major histocompatibility complex, class I, E |
U: 3
D: 2
|
| HLA-F | major histocompatibility complex, class I, F |
U: 3
D: 2
|
| HLA-G | major histocompatibility complex, class I, G |
U: 1
|
| HMGB1 | high mobility group box 1 |
U: 5
D: 8
|
| HMGB2 | high mobility group box 2 |
U: 1
D: 9
|
| HMGB3 | high mobility group box 3 |
D: 1
|
| HMSD | histocompatibility minor serpin domain containing |
D: 2
|
| HRAS | Harvey rat sarcoma virus oncogene |
U: 32
|
| HSPD1 | heat shock protein 1 (chaperonin) |
U: 1
D: 3
|
| HERC6 | hect domain and RLD 6 |
U: 2
|
| ICAM1 | intercellular adhesion molecule 1 |
U: 16
D: 1
|
| ICAM4 | intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
U: 2
|
| ICAM5 | intercellular adhesion molecule 5 |
U: 3
|
| ICOSLG | inducible T cell costimulator ligand |
U: 1
|
| IDO1 | indoleamine 2,3-dioxygenase 1 |
U: 1
D: 3
|
| IFI16 | interferon gamma inducible protein 16 |
U: 4
D: 2
|
| IFI27 | interferon alpha inducible protein 27 |
U: 4
D: 5
|
| IFI44 | interferon-induced protein 44 |
U: 3
|
| IFI44L | interferon-induced protein 44 like |
U: 5
|
| IFI6 | interferon alpha inducible protein 6 |
U: 4
D: 1
|
| IFIH1 | interferon induced with helicase C domain 1 |
U: 2
|
| IFIT5 | interferon induced protein with tetratricopeptide repeats 5 |
U: 1
D: 1
|
| IFITM1 | interferon induced transmembrane protein 1 |
U: 5
D: 2
|
| IFITM2 | interferon induced transmembrane protein 2 |
U: 2
D: 2
|
| IFITM3 | interferon induced transmembrane protein 3 |
U: 2
D: 2
|
| IFNA1 | interferon alpha 1 |
U: 1
|
| IFNB1 | interferon beta 1, fibroblast |
U: 2
|
| IFNE | interferon epsilon |
U: 2
D: 1
|
| IFNG | interferon gamma |
U: 13
|
| IFNLR1 | interferon lambda receptor 1 |
U: 1
|
| IGF1R | insulin-like growth factor I receptor |
U: 9
D: 4
|
| IKBKB | inhibitor of nuclear factor kappa B kinase subunit beta |
U: 2
D: 1
|
| IKBKE | inhibitor of nuclear factor kappa B kinase subunit epsilon |
U: 1
|
| IKBKG | inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
D: 1
|
| IL10 | interleukin 10 |
U: 4
D: 3
|
| IL12A | interleukin 12a |
U: 5
|
| IL13 | interleukin 13 |
U: 3
|
| IL13RA2 | interleukin 13 receptor, alpha 2 |
D: 1
|
| IL15 | interleukin 15 |
U: 5
D: 1
|
| IL16 | interleukin 16 |
U: 1
D: 3
|
| IL18 | interleukin 18 |
U: 8
D: 1
|
| IL18BP | interleukin 18 binding protein |
D: 1
|
| IL18R1 | interleukin 18 receptor 1 |
U: 2
D: 2
|
| IL1R1 | interleukin 1 receptor type 1 |
U: 1
D: 1
|
| IL1R2 | interleukin 1 receptor type 2 |
U: 1
D: 1
|
| IL1RAP | interleukin 1 receptor accessory protein |
U: 3
D: 2
|
| IL1RL1 | interleukin 1 receptor-like 1 |
U: 1
D: 1
|
| IL1RN | interleukin 1 receptor antagonist |
U: 4
D: 1
|
| IL2 | interleukin 2 |
U: 3
D: 2
|
| IL20RB | interleukin 20 receptor beta |
U: 1
D: 1
|
| IL23A | interleukin 23, alpha subunit p19 |
U: 5
D: 1
|
| IL23R | interleukin 23 receptor |
U: 1
|
| IL27RA | interleukin 27 receptor, alpha |
U: 2
D: 1
|
| IL3 | interleukin 3 |
U: 1
|
| IL32 | interleukin 32 |
U: 3
D: 2
|
| IL33 | interleukin 33 |
U: 1
D: 2
|
| IL34 | interleukin 34 |
U: 2
D: 1
|
| IL36B | interleukin 36 beta |
U: 1
|
| IL36RN | interleukin 36 receptor antagonist |
U: 2
|
| IL4 | interleukin 4 |
U: 4
|
| IL4R | interleukin 4 receptor |
U: 2
D: 2
|
| IL5 | interleukin 5 |
U: 1
|
| IL6 | interleukin 6 |
U: 97
D: 20
|
| IL6R | interleukin 6 receptor |
U: 2
D: 1
|
| IL6ST | interleukin 6 signal transducer |
U: 2
D: 1
|
| IL7 | interleukin 7 |
U: 5
|
| IL7R | interleukin 7 receptor |
U: 1
D: 1
|
| IL9 | interleukin 9 |
D: 1
|
| INAVA | innate immunity activator | |
| INPP5D | inositol polyphosphate-5-phosphatase D |
U: 2
D: 1
|
| IPO7 | importin 7 |
D: 1
|
| IRAK1 | interleukin-1 receptor-associated kinase 1 |
U: 2
D: 3
|
| IRAK1BP1 | interleukin-1 receptor-associated kinase 1 binding protein 1 |
D: 3
|
| IRAK4 | interleukin-1 receptor-associated kinase 4 |
U: 1
|
| IRF1 | interferon regulatory factor 1 |
U: 5
D: 1
|
| IRF7 | interferon regulatory factor 7 |
U: 5
D: 1
|
| IRF8 | interferon regulatory factor 8 |
U: 1
|
| ITGA4 | integrin subunit alpha 4 |
U: 1
D: 3
|
| ITGAM | integrin subunit alpha M |
U: 1
D: 1
|
| ITGB1 | integrin subunit beta 1 |
U: 3
D: 1
|
| ITGB7 | integrin subunit beta 7 |
D: 1
|
| ITK | IL2 inducible T cell kinase |
U: 1
|
| IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 |
U: 2
D: 1
|
| IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 |
U: 3
|
| IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 |
U: 3
D: 3
|
| IL1A | interleukin 1 alpha |
U: 31
D: 6
|
| IL1B | interleukin 1 beta |
U: 48
D: 9
|
| ILF2 | interleukin enhancer binding factor 2 |
D: 1
|
| IRF3 | interferon regulatory factor 3 |
U: 3
|
| IRF5 | interferon regulatory factor 5 |
U: 4
D: 1
|
| ISG20 | interferon-stimulated protein |
U: 3
|
| JAK2 | Janus kinase 2 |
U: 3
|
| JAK3 | Janus kinase 3 |
U: 2
|
| KIR2DL4 | killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4 |
U: 1
|
| KLRC2 | killer cell lectin like receptor C2 |
D: 1
|
| KLRG1 | killer cell lectin-like receptor subfamily G, member 1 |
U: 1
D: 1
|
| KLRK1 | killer cell lectin-like receptor subfamily K, member 1 |
U: 1
D: 1
|
| KRT16 | keratin 16 |
U: 1
|
| KARS | lysyl-tRNA synthetase |
D: 1
|
| LAG3 | lymphocyte-activation gene 3 |
D: 1
|
| LAIR2 | leukocyte associated immunoglobulin like receptor 2 |
U: 1
|
| LAMP3 | lysosomal-associated membrane protein 3 |
D: 1
|
| LAT2 | linker for activation of T cells family, member 2 |
U: 3
|
| LCK | lymphocyte protein tyrosine kinase |
U: 1
|
| LCN2 | lipocalin 2 |
U: 2
D: 1
|
| LCP1 | lymphocyte cytosolic protein 1 |
U: 3
|
| LGALS3 | lectin, galactose binding, soluble 3 |
U: 1
D: 2
|
| LGALS9 | lectin, galactose binding, soluble 9 |
U: 3
D: 2
|
| LGR4 | leucine-rich repeat-containing G protein-coupled receptor 4 |
U: 1
D: 1
|
| LIF | leukemia inhibitory factor |
U: 6
D: 3
|
| LILRB3 | leukocyte immunoglobulin like receptor B3 |
D: 1
|
| LRP1 | low density lipoprotein receptor-related protein 1 |
U: 3
D: 1
|
| LRP8 | low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
D: 2
|
| LTA | lymphotoxin A |
U: 1
|
| LTB | lymphotoxin B |
U: 1
|
| LTB4R | leukotriene B4 receptor |
U: 3
|
| LTBR | lymphotoxin B receptor |
U: 1
|
| LTF | lactotransferrin |
U: 1
D: 1
|
| LY96 | lymphocyte antigen 96 |
U: 1
|
| LYAR | Ly1 antibody reactive clone |
D: 4
|
| LYN | LYN proto-oncogene, Src family tyrosine kinase |
D: 1
|
| LPIN1 | lipin 1 |
U: 1
D: 1
|
| MALT1 | MALT1 paracaspase |
D: 2
|
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 |
U: 1
D: 3
|
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 |
U: 1
D: 1
|
| MAP4K2 | mitogen-activated protein kinase kinase kinase kinase 2 |
U: 1
|
| MAPK14 | mitogen-activated protein kinase 14 |
U: 44
D: 6
|
| MAPK3 | mitogen-activated protein kinase 3 |
U: 10
D: 4
|
| MARCHF1 | membrane associated ring-CH-type finger 1 |
D: 1
|
| MATR3 | matrin 3 |
U: 1
|
| MAVS | mitochondrial antiviral signaling protein |
D: 1
|
| MBL2 | mannose-binding lectin (protein C) 2 |
D: 1
|
| MBP | myelin basic protein |
U: 1
D: 2
|
| MCOLN1 | mucolipin 1 |
U: 3
|
| MDK | midkine |
U: 2
D: 2
|
| MEF2C | myocyte enhancer factor 2C |
D: 2
|
| METTL3 | methyltransferase like 3 |
U: 2
|
| MFHAS1 | malignant fibrous histiocytoma amplified sequence 1 |
U: 1
D: 2
|
| MICA | MHC class I polypeptide-related sequence A |
U: 4
D: 1
|
| MICB | MHC class I polypeptide-related sequence B |
U: 4
D: 1
|
| MID2 | midline 2 |
U: 2
|
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
U: 3
D: 5
|
| MIR136 | microRNA 136 |
U: 1
|
| MIR181B1 | microRNA 181b-1 |
U: 1
|
| MIR21 | microRNA 21 |
U: 2
D: 1
|
| MNX1 | motor neuron and pancreas homeobox 1 |
U: 1
|
| MR1 | major histocompatibility complex, class I-related |
U: 3
|
| MSH2 | mutS homolog 2 |
D: 3
|
| MSRB1 | methionine sulfoxide reductase B1 |
U: 2
|
| MUL1 | mitochondrial ubiquitin ligase activator of NFKB 1 |
U: 1
|
| MX1 | MX dynamin like GTPase 1 |
U: 4
|
| MYD88 | myeloid differentiation primary response gene 88 |
U: 1
|
| MYLPF | myosin light chain, phosphorylatable, fast skeletal muscle |
U: 1
|
| MASP1 | mannan-binding lectin serine peptidase 1 |
U: 1
|
| MASP2 | mannan-binding lectin serine peptidase 2 |
U: 1
D: 2
|
| MFSD6 | major facilitator superfamily domain containing 6 |
U: 3
|
| MLH1 | mutL homolog 1 |
D: 1
|
| MMP2 | matrix metallopeptidase 2 |
U: 12
D: 2
|
| NCF2 | neutrophil cytosolic factor 2 |
U: 4
D: 1
|
| NCR3LG1 | natural killer cell cytotoxicity receptor 3 ligand 1 |
U: 1
D: 1
|
| NECTIN1 | nectin cell adhesion molecule 1 |
U: 1
|
| NECTIN2 | nectin cell adhesion molecule 2 |
U: 2
D: 1
|
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 |
U: 2
D: 1
|
| NLRC4 | NLR family, CARD domain containing 4 |
U: 2
|
| NLRC5 | NLR family, CARD domain containing 5 |
U: 3
|
| NLRP1 | NLR family pyrin domain containing 1 |
U: 1
D: 1
|
| NLRP2 | NLR family pyrin domain containing 2 |
U: 1
|
| NLRP3 | NLR family, pyrin domain containing 3 |
U: 6
|
| NLRX1 | NLR family member X1 |
U: 3
|
| NMI | N-myc (and STAT) interactor |
U: 1
|
| NOD1 | nucleotide-binding oligomerization domain containing 1 |
D: 2
|
| NOD2 | nucleotide-binding oligomerization domain containing 2 |
U: 1
D: 1
|
| NONO | non-POU-domain-containing, octamer binding protein |
U: 1
D: 2
|
| NOS2 | nitric oxide synthase 2 |
U: 7
D: 2
|
| NOTCH1 | notch 1 |
U: 8
D: 5
|
| NPDC1 | neural proliferation, differentiation and control 1 |
U: 2
D: 1
|
| NRROS | negative regulator of reactive oxygen species |
U: 2
|
| NDUFS4 | NADH:ubiquinone oxidoreductase core subunit S4 |
U: 1
|
| NPY | neuropeptide Y |
U: 1
D: 2
|
| NRAS | neuroblastoma ras oncogene |
U: 7
|
| OPTN | optineurin |
U: 3
D: 1
|
| ORAI1 | ORAI calcium release-activated calcium modulator 1 |
U: 2
D: 1
|
| OSM | oncostatin M |
U: 1
|
| OTUB1 | OTU domain, ubiquitin aldehyde binding 1 |
D: 1
|
| OTUD4 | OTU domain containing 4 |
U: 1
|
| OTUD7B | OTU domain containing 7B |
D: 1
|
| OAS2 | 2'-5' oligoadenylate synthetase 2 |
U: 3
|
| OAS3 | 2'-5' oligoadenylate synthetase 3 |
U: 2
D: 1
|
| OTUD5 | OTU domain containing 5 |
U: 1
|
| P2RY14 | purinergic receptor P2Y, G-protein coupled, 14 |
D: 2
|
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 |
D: 1
|
| PARP14 | poly (ADP-ribose) polymerase family, member 14 |
U: 4
D: 1
|
| PARP9 | poly (ADP-ribose) polymerase family, member 9 |
U: 4
|
| PCBP2 | poly(rC) binding protein 2 |
U: 1
D: 2
|
| PDCD1 | programmed cell death 1 |
U: 1
D: 1
|
| PDCD1LG2 | programmed cell death 1 ligand 2 |
U: 2
D: 1
|
| PF4 | platelet factor 4 |
U: 3
D: 1
|
| PI3 | peptidase inhibitor 3 |
U: 3
|
| PIANP | PILR alpha associated neural protein |
U: 2
|
| PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
U: 2
D: 2
|
| PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
U: 2
D: 3
|
| PILRB | paired immunoglobin like type 2 receptor beta |
U: 2
|
| PJA2 | praja ring finger ubiquitin ligase 2 |
U: 1
D: 1
|
| PLA2G1B | phospholipase A2, group IB, pancreas |
U: 1
|
| PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) |
U: 1
D: 1
|
| PLA2G5 | phospholipase A2, group V |
U: 1
D: 1
|
| PLCL2 | phospholipase C-like 2 |
D: 2
|
| PLSCR1 | phospholipid scramblase 1 |
U: 2
D: 1
|
| PML | promyelocytic leukemia |
U: 15
D: 2
|
| PNP | purine nucleoside phosphorylase |
U: 1
|
| POLR3B | polymerase (RNA) III (DNA directed) polypeptide B |
D: 1
|
| POLR3C | polymerase (RNA) III (DNA directed) polypeptide C |
D: 1
|
| POLR3D | polymerase (RNA) III (DNA directed) polypeptide D |
U: 1
D: 2
|
| POLR3E | polymerase (RNA) III (DNA directed) polypeptide E |
U: 1
|
| POLR3G | polymerase (RNA) III (DNA directed) polypeptide G |
D: 2
|
| POLR3H | polymerase (RNA) III (DNA directed) polypeptide H |
U: 1
|
| POLR3K | polymerase (RNA) III (DNA directed) polypeptide K |
D: 2
|
| POU2AF1 | POU class 2 homeobox associating factor 1 |
U: 1
|
| POU2F2 | POU domain, class 2, transcription factor 2 |
U: 2
D: 2
|
| PPARG | peroxisome proliferator activated receptor gamma |
U: 7
D: 9
|
| PPBP | pro-platelet basic protein |
U: 3
|
| PPP1R14B | protein phosphatase 1, regulatory inhibitor subunit 14B |
U: 1
D: 1
|
| PPP6C | protein phosphatase 6, catalytic subunit |
U: 1
|
| PRDM1 | PR domain containing 1, with ZNF domain |
U: 1
D: 2
|
| PRELID1 | PRELI domain containing 1 |
D: 2
|
| PRF1 | perforin 1 (pore forming protein) |
D: 2
|
| PRG4 | proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein) |
U: 1
D: 1
|
| PRKCD | protein kinase C, delta |
U: 7
|
| PRKCQ | protein kinase C, theta |
U: 1
|
| PRKD1 | protein kinase D1 |
U: 2
D: 1
|
| PRKD2 | protein kinase D2 |
U: 1
D: 1
|
| PRKDC | protein kinase, DNA activated, catalytic polypeptide |
U: 1
D: 4
|
| PRKRA | protein activator of interferon induced protein kinase EIF2AK2 |
U: 2
D: 2
|
| PRR7 | proline rich 7 (synaptic) |
U: 1
D: 1
|
| PSEN1 | presenilin 1 |
U: 3
|
| PSMB10 | proteasome 20S subunit beta 10 |
U: 2
|
| PSPC1 | paraspeckle protein 1 |
D: 1
|
| PTGDR2 | prostaglandin D2 receptor 2 |
D: 1
|
| PTGER4 | prostaglandin E receptor 4 |
U: 3
D: 2
|
| PTK2 | PTK2 protein tyrosine kinase 2 |
U: 1
D: 4
|
| PTK2B | PTK2 protein tyrosine kinase 2 beta |
U: 1
|
| PTK6 | PTK6 protein tyrosine kinase 6 |
D: 1
|
| PTPN22 | protein tyrosine phosphatase non-receptor type 22 |
D: 2
|
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 |
D: 2
|
| PTPRC | protein tyrosine phosphatase, receptor type, C |
U: 2
D: 2
|
| PTX3 | pentraxin related gene |
U: 6
|
| PVR | PVR cell adhesion molecule |
U: 4
D: 1
|
| PXDN | peroxidasin |
U: 4
D: 1
|
| PYCARD | PYD and CARD domain containing |
U: 1
|
| PYHIN1 | pyrin and HIN domain family member 1 |
U: 1
|
| PLD3 | phospholipase D family, member 3 |
U: 3
|
| PMP22 | peripheral myelin protein 22 |
U: 2
D: 1
|
| PSEN2 | presenilin 2 |
U: 1
|
| PTPRD | protein tyrosine phosphatase, receptor type, D |
D: 1
|
| RAET1E | retinoic acid early transcript 1E |
D: 1
|
| RAET1G | retinoic acid early transcript 1G |
U: 1
|
| RAET1L | retinoic acid early transcript 1L |
U: 1
|
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 |
U: 1
D: 3
|
| RBM14 | RNA binding motif protein 14 |
D: 1
|
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region |
D: 2
|
| REL | reticuloendotheliosis oncogene |
U: 2
D: 1
|
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
U: 12
D: 5
|
| RELB | avian reticuloendotheliosis viral (v-rel) oncogene related B |
U: 2
D: 1
|
| RFX1 | regulatory factor X1 |
U: 1
|
| RGS1 | regulator of G protein signaling 1 |
U: 1
|
| RIOK3 | RIO kinase 3 |
U: 1
|
| RIPK2 | receptor (TNFRSF)-interacting serine-threonine kinase 2 |
U: 1
D: 1
|
| RNASE7 | ribonuclease A family member 7 |
D: 1
|
| RNASET2 | ribonuclease T2 |
U: 2
|
| RNF125 | ring finger protein 125 |
U: 2
D: 1
|
| RNF135 | ring finger protein 135 |
U: 1
|
| RNF166 | ring finger protein 166 |
U: 1
|
| RNF187 | ring finger protein 187 |
U: 1
|
| RNF19B | ring finger protein 19B |
U: 2
|
| RNF39 | ring finger protein 39 |
U: 1
|
| RFPL4B | ret finger protein-like 4B |
U: 1
|
| RPS6 | ribosomal protein S6 |
U: 2
D: 1
|
| RSAD2 | radical S-adenosyl methionine domain containing 2 |
U: 3
|
| S100A7 | S100 calcium binding protein A7 |
D: 1
|
| S100A8 | S100 calcium binding protein A8 (calgranulin A) |
U: 2
|
| S100A9 | S100 calcium binding protein A9 (calgranulin B) |
U: 2
D: 1
|
| S100B | S100 calcium binding protein B |
D: 1
|
| SAA1 | serum amyloid A1 |
U: 5
|
| SAMHD1 | SAM domain and HD domain, 1 |
U: 2
D: 1
|
| SARM1 | sterile alpha and HEAT/Armadillo motif containing 1 |
D: 1
|
| SBNO2 | strawberry notch 2 |
U: 1
D: 1
|
| SCRIB | scribble planar cell polarity protein |
U: 1
|
| SDHAF4 | succinate dehydrogenase complex assembly factor 4 |
U: 1
|
| SEC14L1 | SEC14-like lipid binding 1 |
D: 3
|
| SECTM1 | secreted and transmembrane 1 |
U: 1
D: 1
|
| SELL | selectin L |
U: 1
|
| SEMA3C | semaphorin 3C |
U: 3
D: 1
|
| SEMA7A | semaphorin 7A (John Milton Hagen blood group) |
U: 2
D: 2
|
| SERINC3 | serine incorporator 3 |
U: 1
D: 1
|
| SERINC5 | serine incorporator 5 |
U: 2
D: 1
|
| SERPINB9 | serine (or cysteine) peptidase inhibitor, clade B, member 9 |
D: 1
|
| SERPING1 | serine (or cysteine) peptidase inhibitor, clade G, member 1 |
U: 2
D: 1
|
| SFPQ | splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) |
D: 2
|
| SFTPD | surfactant associated protein D |
U: 1
D: 1
|
| SH2D1A | SH2 domain containing 1A |
U: 2
|
| SIGLEC9 | sialic acid binding Ig like lectin 9 |
U: 1
|
| SIN3A | transcriptional regulator, SIN3A (yeast) |
U: 1
D: 1
|
| SIRPB1 | signal regulatory protein beta 1 |
U: 1
|
| SIRT1 | sirtuin 1 |
U: 12
D: 110
|
| SIRT2 | sirtuin 2 |
U: 2
D: 5
|
| SKP2 | S-phase kinase-associated protein 2 |
U: 1
D: 12
|
| SLAMF7 | SLAM family member 7 |
U: 1
|
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
U: 1
|
| SLPI | secretory leukocyte peptidase inhibitor |
U: 2
D: 1
|
| SMAD3 | SMAD family member 3 |
U: 8
D: 2
|
| SMAD6 | SMAD family member 6 |
D: 1
|
| SMAD7 | SMAD family member 7 |
U: 2
D: 1
|
| SMPDL3B | sphingomyelin phosphodiesterase, acid-like 3B |
U: 1
|
| SPHK2 | sphingosine kinase 2 |
D: 1
|
| SPINK5 | serine peptidase inhibitor Kazal type 5 |
U: 1
|
| SPNS2 | spinster homolog 2 |
U: 2
D: 1
|
| SPON2 | spondin 2, extracellular matrix protein |
U: 4
|
| SPPL2B | signal peptide peptidase like 2B |
U: 1
D: 1
|
| SRC | Rous sarcoma oncogene |
U: 2
D: 6
|
| SRPK1 | SRSF protein kinase 1 |
D: 1
|
| SRPK2 | SRSF protein kinase 2 |
U: 1
|
| SSC5D | scavenger receptor cysteine rich family, 5 domains |
U: 3
|
| STAT6 | signal transducer and activator of transcription 6 |
U: 4
|
| STING1 | stimulator of interferon response cGAMP interactor 1 |
U: 2
|
| STYK1 | serine/threonine/tyrosine kinase 1 |
U: 1
|
| SYK | spleen tyrosine kinase |
U: 3
D: 2
|
| SEMA4A | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
D: 2
|
| SETD2 | SET domain containing 2 |
U: 1
D: 1
|
| SH2B2 | SH2B adaptor protein 2 |
U: 1
D: 1
|
| SP110 | Sp110 nuclear body protein |
U: 3
|
| STARD7 | START domain containing 7 |
U: 1
|
| SUSD2 | sushi domain containing 2 |
D: 1
|
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
U: 3
|
| TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
U: 3
D: 1
|
| TAPBP | TAP binding protein |
U: 1
|
| TBK1 | TANK-binding kinase 1 |
U: 2
|
| TCF12 | transcription factor 12 |
D: 3
|
| TCF7 | transcription factor 7 |
U: 1
D: 1
|
| TCIM | transcriptional and immune response regulator | |
| TCIRG1 | T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 |
U: 1
D: 1
|
| TENM1 | teneurin transmembrane protein 1 |
U: 1
D: 1
|
| TFE3 | transcription factor E3 |
U: 2
|
| TFEB | transcription factor EB |
D: 3
|
| TGFB2 | transforming growth factor, beta 2 |
U: 5
D: 1
|
| TGFBR3 | transforming growth factor, beta receptor III |
U: 3
D: 2
|
| THBS1 | thrombospondin 1 |
U: 7
D: 4
|
| TICAM1 | toll-like receptor adaptor molecule 1 |
U: 1
|
| TIFA | TRAF-interacting protein with forkhead-associated domain |
U: 2
|
| TLR1 | toll-like receptor 1 |
U: 2
|
| TLR10 | toll like receptor 10 |
U: 1
|
| TLR2 | toll-like receptor 2 |
U: 3
D: 1
|
| TLR3 | toll-like receptor 3 |
U: 4
D: 1
|
| TLR4 | toll-like receptor 4 |
U: 7
D: 2
|
| TLR5 | toll-like receptor 5 |
U: 1
D: 1
|
| TLR6 | toll-like receptor 6 |
U: 1
D: 1
|
| TLR9 | toll-like receptor 9 |
U: 1
D: 1
|
| TMEM106A | transmembrane protein 106A |
U: 1
|
| TNF | tumor necrosis factor |
U: 48
D: 7
|
| TNFAIP1 | TNF alpha induced protein 1 |
U: 1
|
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
U: 3
D: 1
|
| TNFRSF11A | tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
U: 1
D: 1
|
| TNFRSF13C | tumor necrosis factor receptor superfamily, member 13c |
D: 1
|
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
U: 2
|
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1b |
U: 3
D: 3
|
| TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 |
U: 3
D: 2
|
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 |
U: 5
D: 3
|
| TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 |
U: 5
|
| TNFSF12 | tumor necrosis factor (ligand) superfamily, member 12 |
U: 1
|
| TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 |
D: 1
|
| TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b |
U: 3
D: 4
|
| TNFSF15 | tumor necrosis factor (ligand) superfamily, member 15 |
U: 4
D: 1
|
| TNFSF18 | tumor necrosis factor (ligand) superfamily, member 18 |
U: 1
|
| TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
U: 1
D: 1
|
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 |
U: 2
|
| TNFSF9 | tumor necrosis factor (ligand) superfamily, member 9 |
U: 2
|
| TOLLIP | toll interacting protein |
U: 2
|
| TP53 | tumor protein p53 |
U: 243
D: 9
|
| TRAF3 | TNF receptor-associated factor 3 |
U: 2
|
| TRAF6 | TNF receptor-associated factor 6 |
U: 1
D: 3
|
| TRAFD1 | TRAF type zinc finger domain containing 1 |
U: 1
D: 1
|
| TREM1 | triggering receptor expressed on myeloid cells 1 |
U: 2
|
| TREM2 | triggering receptor expressed on myeloid cells 2 |
D: 1
|
| TREX1 | three prime repair exonuclease 1 |
U: 1
D: 2
|
| TRIL | TLR4 interactor with leucine-rich repeats |
D: 2
|
| TRIM14 | tripartite motif-containing 14 |
U: 1
D: 1
|
| TRIM17 | tripartite motif-containing 17 |
U: 1
D: 2
|
| TRIM21 | tripartite motif-containing 21 |
U: 1
D: 2
|
| TRIM22 | tripartite motif containing 22 |
U: 3
D: 1
|
| TRIM23 | tripartite motif containing 23 |
U: 1
|
| TRIM25 | tripartite motif-containing 25 |
U: 1
|
| TRIM26 | tripartite motif-containing 26 |
U: 1
|
| TRIM27 | tripartite motif-containing 27 |
D: 1
|
| TRIM28 | tripartite motif-containing 28 |
U: 2
D: 1
|
| TRIM29 | tripartite motif-containing 29 |
U: 3
|
| TRIM35 | tripartite motif-containing 35 |
U: 2
|
| TRIM38 | tripartite motif-containing 38 |
U: 1
|
| TRIM4 | tripartite motif containing 4 |
U: 1
|
| TRIM56 | tripartite motif-containing 56 |
U: 1
|
| TRIM58 | tripartite motif-containing 58 |
U: 1
|
| TRIM59 | tripartite motif-containing 59 |
D: 2
|
| TRIM6 | tripartite motif-containing 6 |
D: 1
|
| TRIM62 | tripartite motif-containing 62 |
U: 1
|
| TRIM68 | tripartite motif-containing 68 |
D: 1
|
| TRIM8 | tripartite motif-containing 8 |
U: 2
|
| TRPM4 | transient receptor potential cation channel, subfamily M, member 4 |
U: 1
|
| TSC1 | TSC complex subunit 1 |
U: 1
|
| TTC4 | tetratricopeptide repeat domain 4 |
D: 2
|
| TYRO3 | TYRO3 protein tyrosine kinase 3 |
U: 1
D: 2
|
| TAC1 | tachykinin 1 |
U: 1
|
| TBX21 | T-box 21 |
U: 3
|
| TEK | TEK receptor tyrosine kinase |
D: 3
|
| TGFB1 | transforming growth factor, beta 1 |
U: 49
D: 6
|
| TINAGL1 | tubulointerstitial nephritis antigen-like 1 |
U: 2
D: 3
|
| TTLL1 | tubulin tyrosine ligase-like 1 |
U: 1
|
| ULBP1 | UL16 binding protein 1 |
U: 3
D: 1
|
| ULBP2 | UL16 binding protein 2 |
U: 4
|
| ULBP3 | UL16 binding protein 3 |
U: 1
|
| UNC93B1 | unc-93 homolog B1, TLR signaling regulator |
U: 1
D: 1
|
| USP14 | ubiquitin specific peptidase 14 |
U: 1
|
| VCAM1 | vascular cell adhesion molecule 1 |
U: 4
D: 4
|
| VNN1 | vanin 1 |
U: 2
D: 2
|
| VSIR | V-set immunoregulatory receptor |
U: 2
D: 1
|
| VTCN1 | V-set domain containing T cell activation inhibitor 1 |
U: 1
|
| VTN | vitronectin |
D: 2
|
| VEGFA | vascular endothelial growth factor A |
U: 10
D: 5
|
| VIP | vasoactive intestinal polypeptide |
U: 1
|
| WFDC3 | WAP four-disulfide core domain 3 |
U: 1
|
| WNT5A | wingless-type MMTV integration site family, member 5A |
U: 4
|
| XBP1 | X-box binding protein 1 |
U: 3
D: 1
|
| XCL1 | chemokine (C motif) ligand 1 |
U: 1
D: 1
|
| XIAP | X-linked inhibitor of apoptosis |
U: 2
D: 1
|
| XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 |
U: 1
D: 7
|
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 |
U: 1
D: 3
|
| YES1 | YES proto-oncogene 1, Src family tyrosine kinase |
U: 1
D: 1
|
| ZC3H12A | zinc finger CCCH type containing 12A |
U: 3
D: 1
|
| ZC3HAV1 | zinc finger CCCH type, antiviral 1 |
U: 1
D: 1
|
| ZCCHC3 | zinc finger, CCHC domain containing 3 |
U: 1
D: 1
|